ZA961018B - Oral dosage-forms containing a beta-lactam antibiotic. - Google Patents
Oral dosage-forms containing a beta-lactam antibiotic.Info
- Publication number
- ZA961018B ZA961018B ZA9601018A ZA961018A ZA961018B ZA 961018 B ZA961018 B ZA 961018B ZA 9601018 A ZA9601018 A ZA 9601018A ZA 961018 A ZA961018 A ZA 961018A ZA 961018 B ZA961018 B ZA 961018B
- Authority
- ZA
- South Africa
- Prior art keywords
- pct
- beta
- lactam antibiotic
- granulate
- oral dosage
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP95200313 | 1995-02-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA961018B true ZA961018B (en) | 1997-08-08 |
Family
ID=8220003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9601018A ZA961018B (en) | 1995-02-08 | 1996-02-08 | Oral dosage-forms containing a beta-lactam antibiotic. |
Country Status (19)
Country | Link |
---|---|
US (1) | US5948422A (da) |
EP (1) | EP0801559B1 (da) |
CN (1) | CN1125636C (da) |
AT (1) | ATE216576T1 (da) |
AU (1) | AU4789696A (da) |
BG (1) | BG63528B1 (da) |
BR (1) | BR9607189A (da) |
CZ (1) | CZ293718B6 (da) |
DE (1) | DE69620866T2 (da) |
DK (1) | DK0801559T3 (da) |
EA (2) | EA000361B1 (da) |
ES (1) | ES2175073T3 (da) |
HU (1) | HU227938B1 (da) |
MX (1) | MX9706062A (da) |
NO (1) | NO319993B1 (da) |
PL (1) | PL186386B1 (da) |
PT (1) | PT801559E (da) |
WO (1) | WO1996024337A1 (da) |
ZA (1) | ZA961018B (da) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI225402B (en) * | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
US6242006B1 (en) | 1996-07-16 | 2001-06-05 | Gist-Brocades B.V. | β-lactam granules free of organic solvents |
US6080427A (en) * | 1997-04-17 | 2000-06-27 | Bristol-Myers Squibb Company | Cefadroxil monohydrate tablet formulation |
CA2322315C (en) * | 1998-03-06 | 2008-09-16 | Eurand International S.P.A. | Fast disintegrating tablets |
US7399751B2 (en) * | 1999-11-04 | 2008-07-15 | Sertoli Technologies, Inc. | Production of a biological factor and creation of an immunologically privileged environment using genetically altered Sertoli cells |
DE19922537A1 (de) * | 1999-05-10 | 2000-11-16 | Roland Bodmeier | Darreichungsform zur Applikation in Körperöffnungen |
AU2001288102A1 (en) * | 2000-09-22 | 2002-04-02 | Takeda Chemical Industries Ltd. | Solid preparations |
GB0102342D0 (en) * | 2001-01-30 | 2001-03-14 | Smithkline Beecham Plc | Pharmaceutical formulation |
HUP0303178A3 (en) * | 2001-02-05 | 2008-03-28 | R P Scherer Technologies | Methods and compositions for reducing the taste of pharmaceutically active agents |
PL212421B1 (pl) * | 2002-03-12 | 2012-09-28 | Bristol Myers Squibb Co | Kompozycja farmaceutyczna w postaci zawiesiny kwasowego leku i sposób jej wytwarzania oraz sposób maskowania gorzkiego lub innego nieprzyjemnego smaku leku |
US8648065B2 (en) * | 2002-10-02 | 2014-02-11 | Meiji Seika Pharma Co., Ltd. | Antibacterial medicinal composition of enhanced oral absorptivity |
WO2004056363A2 (en) * | 2002-12-20 | 2004-07-08 | Niconovum Ab | A physically and chemically stable nicotine-containing particulate material |
JP4926703B2 (ja) * | 2003-07-03 | 2012-05-09 | セルトリ・テクノロジーズ・エルエルシー | セルトリ細胞および筋様細胞を含有する組成物、並びに細胞性移植における該組成物の使用 |
WO2005021056A1 (en) * | 2003-08-21 | 2005-03-10 | Cns, Inc. | Effervescent delivery system |
CA2626933C (en) * | 2005-11-17 | 2015-12-29 | Novartis Ag | Pharmaceutical composition |
CA2646942C (en) | 2006-03-16 | 2014-07-29 | Niconovum Ab | Improved snuff composition |
US8617597B2 (en) | 2006-07-06 | 2013-12-31 | Bayer Intellectual Property Gmbh | Pharmaceutical composition containing a tetrahydrofolic acid |
AU2007278850B2 (en) * | 2006-07-28 | 2013-06-06 | Sertocell Biotechnology (Us) Corp. | Adult sertoli cells and uses thereof |
CA2736531C (en) * | 2008-09-17 | 2016-10-25 | Niconovum Ab | Process for preparing snuff composition |
EP2367422A4 (en) * | 2008-12-17 | 2013-01-09 | Altheus Therapeutics Inc | FORMULAS FOR LAVATION |
WO2023204773A1 (en) * | 2022-04-20 | 2023-10-26 | Bilim Ilac Sanayii Ve Ticaret A.S. | Tablet formulations for the treatment of urinary system infections and method for the preparation of such formulations |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3344030A (en) * | 1964-06-15 | 1967-09-26 | American Home Prod | Reinforced directly compressed nongranulated pharmaceutical crystalline lactose tables |
DE2251250C3 (de) * | 1972-10-19 | 1981-06-25 | Hoechst Ag, 6230 Frankfurt | Verfahren zur Herstellung hochdosierter Antibiotica-Tabletten |
DE2251249A1 (de) * | 1972-10-19 | 1974-05-02 | Hoechst Ag | Verfahren zur herstellung von penicillin-verbindungen enthaltenden tabletten |
EP0281200B1 (en) * | 1987-03-02 | 1994-01-19 | Yamanouchi Europe B.V. | Pharmaceutical composition, pharmaceutical granulate and process for their preparation |
US5049394A (en) * | 1987-09-11 | 1991-09-17 | E. R. Squibb & Sons, Inc. | Pharmaceutical composition containing high drug load and method for preparing same |
EP0330284B1 (en) * | 1988-02-25 | 1994-07-27 | Yamanouchi Europe B.V. | Process for the preparation of a pharmaceutical granulate |
US5643591A (en) * | 1991-01-16 | 1997-07-01 | Fmc Corporation | Solid dosage forms |
DE69525151T2 (de) * | 1994-04-13 | 2002-08-14 | Res Corp Technologies Inc | Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat |
US5605889A (en) * | 1994-04-29 | 1997-02-25 | Pfizer Inc. | Method of administering azithromycin |
-
1996
- 1996-02-08 EA EA199700093A patent/EA000361B1/ru not_active IP Right Cessation
- 1996-02-08 DE DE69620866T patent/DE69620866T2/de not_active Expired - Lifetime
- 1996-02-08 HU HU9801677A patent/HU227938B1/hu not_active IP Right Cessation
- 1996-02-08 DK DK96904039T patent/DK0801559T3/da active
- 1996-02-08 AT AT96904039T patent/ATE216576T1/de active
- 1996-02-08 WO PCT/EP1996/000547 patent/WO1996024337A1/en active IP Right Grant
- 1996-02-08 CN CN96191852A patent/CN1125636C/zh not_active Expired - Fee Related
- 1996-02-08 ZA ZA9601018A patent/ZA961018B/xx unknown
- 1996-02-08 EA EA199900205A patent/EA003736B1/ru not_active IP Right Cessation
- 1996-02-08 MX MX9706062A patent/MX9706062A/es unknown
- 1996-02-08 PT PT96904039T patent/PT801559E/pt unknown
- 1996-02-08 CZ CZ19972302A patent/CZ293718B6/cs not_active IP Right Cessation
- 1996-02-08 US US08/894,602 patent/US5948422A/en not_active Expired - Lifetime
- 1996-02-08 ES ES96904039T patent/ES2175073T3/es not_active Expired - Lifetime
- 1996-02-08 BR BR9607189A patent/BR9607189A/pt active Search and Examination
- 1996-02-08 AU AU47896/96A patent/AU4789696A/en not_active Abandoned
- 1996-02-08 PL PL96321567A patent/PL186386B1/pl unknown
- 1996-02-08 EP EP96904039A patent/EP0801559B1/en not_active Expired - Lifetime
-
1997
- 1997-08-07 NO NO19973646A patent/NO319993B1/no not_active IP Right Cessation
- 1997-08-08 BG BG101822A patent/BG63528B1/bg unknown
Also Published As
Publication number | Publication date |
---|---|
EA199700093A1 (ru) | 1998-02-26 |
MX9706062A (es) | 1997-10-31 |
HUP9801677A2 (hu) | 1998-11-30 |
EA199900205A1 (ru) | 2000-06-26 |
EP0801559A1 (en) | 1997-10-22 |
PL321567A1 (en) | 1997-12-08 |
DE69620866D1 (de) | 2002-05-29 |
BG101822A (en) | 1998-04-30 |
CN1125636C (zh) | 2003-10-29 |
CN1173816A (zh) | 1998-02-18 |
EA000361B1 (ru) | 1999-06-24 |
HU227938B1 (en) | 2012-06-28 |
BR9607189A (pt) | 1997-11-11 |
AU4789696A (en) | 1996-08-27 |
EA003736B1 (ru) | 2003-08-28 |
NO973646L (no) | 1997-09-11 |
DE69620866T2 (de) | 2003-02-27 |
CZ293718B6 (cs) | 2004-07-14 |
EP0801559B1 (en) | 2002-04-24 |
NO319993B1 (no) | 2005-10-10 |
WO1996024337A1 (en) | 1996-08-15 |
BG63528B1 (bg) | 2002-04-30 |
CZ230297A3 (en) | 1997-11-12 |
NO973646D0 (no) | 1997-08-07 |
ES2175073T3 (es) | 2002-11-16 |
US5948422A (en) | 1999-09-07 |
PL186386B1 (pl) | 2004-01-30 |
HUP9801677A3 (en) | 1999-05-28 |
PT801559E (pt) | 2002-09-30 |
ATE216576T1 (de) | 2002-05-15 |
DK0801559T3 (da) | 2002-06-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA961018B (en) | Oral dosage-forms containing a beta-lactam antibiotic. | |
IL115309A0 (en) | Pharmaceutical preparation containing metformin and processes for the production thereof | |
TW263499B (da) | ||
ZA973647B (en) | Inhibitors of metalloprotease, process for preparing them and pharmaceutical compositions containing them. | |
ZA965237B (en) | A composition and a process for the preparation thereof | |
JO1969B1 (en) | Granulation process for the preparation of rapidly dissolving and dissolving compounds containing a high amount of the drug | |
GB9821387D0 (en) | Hydrocolloid confectionery | |
UA42745C2 (uk) | Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин | |
ZA959451B (en) | 2,2-Dichloroalkanecarboxylic acids process of their production and pharmaceutical agents containing these | |
GB9517883D0 (en) | Improved pharmaceutical ion exchange resin composition | |
HU9700903D0 (en) | Sulfonamide-substituted chromanes, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them | |
HUT77128A (hu) | 1,2,4-Triazol-származékok, eljárás előállításukra és az ezeket tartalmazó gyógyszerkészítmények | |
HUP9601358A3 (en) | Fluoro-phenyl-substituted alkenyl-carboxylic-guanidines, process for producing them, their use as medicines or diagnostica, and pharmaceutical compositions containing them | |
HU9601321D0 (en) | Substituted (benzyloxy)-carbonyl-guanidine derivatives, process for producing them, their use as pharmaceutical compositions or diagnostica, and pharmaceutical compositions containing them | |
BR9909637A (pt) | Processo para a produção de um tablete de uma composição particulada compactada, tablete de composição particulada compactada, e, usos de cristais ou acetato de sódio hidratado ou anidro, acetato de potássio ou misturas dos mesmos e de cristais ou triidrato de acetato de sódio hidratado ou anidro, acetato de potássio ou mistura dos mesmos | |
HUP9802492A3 (en) | Benzisoxazole and indazole derivatives as antipsychotic agents, process for their preparation and pharmaceutical compositions containing the same | |
HUP9901260A3 (en) | Optically active phenylpyrimidine derivative as analgesic agent, process for producing it, pharmaceutical composition containing it and its intermediate | |
GR3036220T3 (en) | Process for reducing sulfur and vat dyes | |
HUP9900263A3 (en) | 11-acetyl-12,13-dioxabicyclo[8.2.1.]tridecenon derivatives, process for producing them and pharmaceutical compositions containing them | |
TW334424B (en) | L-arginine aldehyde derivatives process for preparing them and pharmaceutical composition | |
IL117734A0 (en) | Beta-carbolines and pharmaceutical compositions containing them | |
HU9401032D0 (en) | New benzimidazol-2-yl derivatives, process for producing them and pharmaceutical compositions containing them | |
HUT66204A (en) | Phytoactive compositions containing n-phosphonomethyl-clycine monoammonium salts as active ingredients and process for producing the compositions and the active ingredients |